Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Eur J Clin Pharmacol. 2012 Jan 21;68(6):937–942. doi: 10.1007/s00228-011-1208-z

Table 3. Determinants of dexmedetomidine clearance in ICU patients.

The table presents posterior means and 95 % credible intervals for the parameters from the Bayesian hierarchical nonlinear mixture model

Parameter Posterior mean 95 % credible interval
Smoking 0.147 −0.246 to 0.545
Weight 0.008 −0.0003 to 0.016
Age −0.002 −0.017 to 0.012
Genotype (SM vs NM) 0.321 −0.690 to 1.348
Genotype (IM vs NM) 0.139 −0.473 to 0.779

The following equation takes into account the posterior means and was used to determine the subject-specific clearance.

Cli = 0.147×Smoking + 0.008×Weight0.002×Age + 0.321×SM + 0.139×IM, where Cli is subject specific clearance, Smoking is an indicator for smoking status (Smoking = 1 if a subject is smoker, and Smoking = 0 for nonsmoker), Weight is body weight in kg, Age is age in years, SM is an indicator for slow metabolizer (SM=1 if a subject is slow metabolizer, and SM = 0 otherwise) and IM is an indicator for intermediate metabolizer (IM = 1 if a subject is intermediate metabolizer, and IM = 0 otherwise).